Hospira, Inc. recalls Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02),

Recalled December 11, 2013 · FDA recall D-023-2014 · Hospira

Hazard

Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck. · FDA Class II

Units

29,700 vials

Sold at

Nationwide

Description

Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.

Product

Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA.

Manufacturer(s)

Hospira, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →